| BURU 0.2231 0.86% | PLUG 3.81 34.63% | ASNS 0.6247 68.84% | DFLI 1.89 76.64% | CHR 0.1609 22.64% | OPEN 8.11 1.25% | SOXS 4.69 1.96% | BNAI 0.6015 69.44% | TSLL 19.63 -2.92% | RKT 17.8 -3.10% | LAC 9.04 31.78% | SNAP 8.54 3.89% | RGTI 40.06 13.16% | NVDA 187.62 -0.67% | TSLA 429.83 -1.42% | CAN 1.31 -0.76% | INTC 36.83 -1.26% | SQQQ 15.05 1.42% | DNN 2.8 1.08% | QUBT 24.62 23.22% | PSLV 16.13 2.35% | GPUS 0.54 11.57% | ACHR 11.57 13.65% | PLTR 173.07 -7.47% | RR 6.18 19.77% | F 12.67 3.68% | QBTS 32.7 11.95% | BBAI 7.19 -1.10% | TLRY 1.62 0.62% | TSLQ 8.51 2.78% | IBIT 69.81 1.51% | SOFI 25.24 -2.81% | AAL 11.58 1.31% | IONZ 3.4 -11.92% | QS 15.92 11.33% | SOUN 17.85 0.06% | DVLT 1.34 -12.42% | ONDS 9.91 7.60% | PFE 27.37 1.07% | SOXL 38.23 -2.18% | CIFR 14.7 6.44% | SPY 669.21 0.00% | HIVE 4.45 2.06% | CJET 0.169 -0.59% | BITF 3.01 2.73% | BBD 3.17 0.11% | SHOT 0.3702 31.74% | ANRO 6.89 56.24% | NIO 7.7 -2.41% | MARA 18.82 0.16%
Article image

Aehr Test Systems, Inc. (NASDAQ: AEHR) Reports Q4 Fiscal 2025 Financial Results

Aehr Test Systems, Inc. (NASDAQ: AEHR) is a global provider of semiconductor test and burn-in equipment. The company recently reported its financial results for the fourth quarter of fiscal 2025, ending May 30, 2025. Despite facing challenges, AEHR managed to report an earnings per share (EPS) of -$0.01, which was better than the estimated EPS of -$0.015. However, the company generated a revenue of $14.1 million, falling short of the estimated $14.8 million.

During the Q4 2025 earnings conference call on July 8, 2025, key company figures such as CFO Chris P. Siu and CEO Gayn Erickson discussed the financial results. Analysts from Craig-Hallum Capital Group LLC and William Blair & Company L.L.C. also participated. The call highlighted AEHR's net revenue of $14.1 million for the fourth quarter, a decrease from $16.6 million in the same quarter of fiscal 2024.

Aehr Test Systems reported a GAAP net loss of $2.9 million, or $0.10 per diluted share, contrasting with a GAAP net income of $23.9 million, or $0.81 per diluted share, in the previous year. This previous year's income included a significant tax benefit of approximately $20.7 million. On a non-GAAP basis, excluding certain adjustments, the company reported a net loss of $0.2 million, or $0.01 per diluted share, compared to a non-GAAP net income of $24.7 million, or $0.84 per diluted share, in the fourth quarter of fiscal 2024.

Despite these challenges, AEHR is expanding its total addressable market and diversifying its customer base. The company has a price-to-sales ratio of about 7.35. Its enterprise value to sales ratio is around 6.97. AEHR maintains a low debt-to-equity ratio of about 0.052, indicating a conservative use of debt. Additionally, the company has a strong current ratio of approximately 5.71, suggesting a robust ability to cover its short-term liabilities with its short-term assets.

Published on: July 9, 2025